Chicungunya

Page 1

AVR 3649

No. of Pages 10, Model 5G

16 June 2015 Antiviral Research xxx (2015) xxx–xxx 1

Contents lists available at ScienceDirect

Antiviral Research journal homepage: www.elsevier.com/locate/antiviral

2

Review

5 4 6

Cellular and molecular mechanisms of chikungunya pathogenesis

7 8 9 10 11 12 1 2 4 6 15 16 17 18 19 20 21 22 23 24 25

Fok-Moon Lum a,b, Lisa F.P. Ng a,b,c,⇑ a

Singapore Immunology Network, Agency for Science, Technology and Research (A⁄STAR), Singapore Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore c Institute of Infection and Global Health, University of Liverpool, United Kingdom b

a r t i c l e

i n f o

a b s t r a c t

Article history: Received 6 May 2015 Revised 27 May 2015 Accepted 16 June 2015 Available online xxxx

Chikungunya virus (CHIKV) is an arthropod-borne virus that causes chikungunya fever, a disease characterized by the onset of fever and rashes, with arthralgia as its hallmark symptom. CHIKV has re-emerged over the past decade, causing numerous outbreaks around the world. Since late 2013, CHIKV has reached the shores of the Americas, causing more than a million cases of infection. Despite concentrated efforts to understand the pathogenesis of the disease, further outbreaks remain a threat. This review highlights important findings regarding CHIKV-associated immunopathogenesis and offers important insights into future directions. This article forms part of a symposium in Antiviral Research on ‘‘Chikungunya discovers the New World.’’ Ó 2015 Published by Elsevier B.V.

Keywords: Chikungunya virus Immune response Immunopathogenesis Pathology

27 28 29 30 31 32 33 34 35 36 37

38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57

Contents 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16.

Introduction . . . . . . . . . . . . . The virus . . . . . . . . . . . . . . . . Replication cycle . . . . . . . . . Route of infection. . . . . . . . . Target cells . . . . . . . . . . . . . . Apoptosis and autophagy . . Importance of Type I IFN . . . Cytokines and chemokines . IL-6 and osteoclastogenesis . Monocytes/macrophages . . . NK cells . . . . . . . . . . . . . . . . . Dendritic cells. . . . . . . . . . . . T cells . . . . . . . . . . . . . . . . . . B cells . . . . . . . . . . . . . . . . . . Future perspectives . . . . . . . Uncited references . . . . . . . . Acknowledgements . . . . . . . References . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . .

00 00 00 00 00 00 00 00 00 00 00 00 00 00 00 00 00 00

58 59

60

1. Introduction

61

Chikungunya virus (CHIKV) is an alphavirus belonging to the Togaviridae family that was first isolated from a human patient in

62

⇑ Corresponding author at: Singapore Immunology Network, Agency for Science, Technology and Research (A⁄STAR), Singapore. E-mail address: lisa_ng@immunol.a-star.edu.sg (L.F.P. Ng).

Tanzania in 1952. It is transmitted mainly by the Aedes agypti and Aedes albopictus mosquitoes. Infection causes a self-limiting febrile illness known as chikungunya fever (CHIKF) with symptoms such as myalgia, fever and rashes. Patients also typically exhibit polyarthralgia, which is a hallmark of the disease. Symptoms usually appear after an incubation period of 4–7 days. While many of the symptoms disappear within the following week, arthralgia may persist in some patients for up to a few years (Her et al., 2009; Kam

http://dx.doi.org/10.1016/j.antiviral.2015.06.009 0166-3542/Ó 2015 Published by Elsevier B.V.

Please cite this article in press as: Lum, F.-M., Ng, L.F.P. Cellular and molecular mechanisms of chikungunya pathogenesis. Antiviral Res. (2015), http:// dx.doi.org/10.1016/j.antiviral.2015.06.009

63 64 65 66 67 68 69 70


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.